1. Home
  2. PRME vs DDI Comparison

PRME vs DDI Comparison

Compare PRME & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • DDI
  • Stock Information
  • Founded
  • PRME 2019
  • DDI 2008
  • Country
  • PRME United States
  • DDI South Korea
  • Employees
  • PRME N/A
  • DDI N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • DDI EDP Services
  • Sector
  • PRME Health Care
  • DDI Technology
  • Exchange
  • PRME Nasdaq
  • DDI Nasdaq
  • Market Cap
  • PRME 191.7M
  • DDI 489.1M
  • IPO Year
  • PRME 2022
  • DDI 2021
  • Fundamental
  • Price
  • PRME $3.14
  • DDI $9.73
  • Analyst Decision
  • PRME Buy
  • DDI Strong Buy
  • Analyst Count
  • PRME 6
  • DDI 5
  • Target Price
  • PRME $9.38
  • DDI $19.60
  • AVG Volume (30 Days)
  • PRME 3.7M
  • DDI 134.8K
  • Earning Date
  • PRME 08-04-2025
  • DDI 08-11-2025
  • Dividend Yield
  • PRME N/A
  • DDI N/A
  • EPS Growth
  • PRME N/A
  • DDI 9.79
  • EPS
  • PRME N/A
  • DDI 2.37
  • Revenue
  • PRME $3,846,000.00
  • DDI $336,679,000.00
  • Revenue This Year
  • PRME $104.12
  • DDI $8.25
  • Revenue Next Year
  • PRME $196.78
  • DDI $3.39
  • P/E Ratio
  • PRME N/A
  • DDI $4.10
  • Revenue Growth
  • PRME 550.76
  • DDI 5.41
  • 52 Week Low
  • PRME $1.11
  • DDI $8.09
  • 52 Week High
  • PRME $6.75
  • DDI $18.21
  • Technical
  • Relative Strength Index (RSI)
  • PRME 79.25
  • DDI 52.17
  • Support Level
  • PRME $2.28
  • DDI $9.37
  • Resistance Level
  • PRME $2.78
  • DDI $9.84
  • Average True Range (ATR)
  • PRME 0.34
  • DDI 0.35
  • MACD
  • PRME 0.12
  • DDI 0.06
  • Stochastic Oscillator
  • PRME 81.62
  • DDI 92.64

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About DDI DoubleDown Interactive Co. Ltd. American Depository Shares

DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. Its market opportunity includes casual gaming globally, which includes slots, puzzles, cards, match three, and other similar games. Within the social casino segment of casual gaming, which includes free-to-play online slots, poker, table games, and bingo. Other games developed by the company are DoubleDown Fort, DoubleDown Classic, and Ellen's Road to Riches. The company has a presence in the international market, and it derives a majority of its revenue from the United States of America.

Share on Social Networks: